Y Intercept Hong Kong Ltd Raises Stock Position in Ventas, Inc. $VTR

Y Intercept Hong Kong Ltd boosted its holdings in Ventas, Inc. (NYSE:VTR) by 28.5% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 83,524 shares of the real estate investment trust’s stock after acquiring an additional 18,527 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Ventas were worth $5,846,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Resona Asset Management Co. Ltd. lifted its position in Ventas by 8.1% in the third quarter. Resona Asset Management Co. Ltd. now owns 271,652 shares of the real estate investment trust’s stock valued at $18,849,000 after buying an additional 20,451 shares during the last quarter. UniSuper Management Pty Ltd boosted its position in shares of Ventas by 7.2% during the third quarter. UniSuper Management Pty Ltd now owns 180,288 shares of the real estate investment trust’s stock worth $12,618,000 after buying an additional 12,146 shares during the period. Teacher Retirement System of Texas boosted its position in shares of Ventas by 12.6% during the third quarter. Teacher Retirement System of Texas now owns 248,421 shares of the real estate investment trust’s stock worth $17,387,000 after buying an additional 27,865 shares during the period. iA Global Asset Management Inc. grew its stake in shares of Ventas by 25.7% in the third quarter. iA Global Asset Management Inc. now owns 31,701 shares of the real estate investment trust’s stock valued at $2,219,000 after buying an additional 6,473 shares in the last quarter. Finally, Strs Ohio lifted its stake in Ventas by 15.6% during the 3rd quarter. Strs Ohio now owns 669,984 shares of the real estate investment trust’s stock worth $46,892,000 after acquiring an additional 90,605 shares in the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Ventas Stock Performance

Shares of VTR opened at $76.94 on Friday. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 1.01. The company has a market capitalization of $36.14 billion, a PE ratio of 147.95, a P/E/G ratio of 1.91 and a beta of 0.78. Ventas, Inc. has a 52-week low of $58.72 and a 52-week high of $81.89. The company has a 50-day simple moving average of $78.51 and a 200-day simple moving average of $72.36.

Ventas (NYSE:VTR) last released its quarterly earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.87 by $0.01. The business had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.44 billion. Ventas had a return on equity of 2.05% and a net margin of 4.28%.The business’s revenue was up 20.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.80 EPS. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. Equities research analysts predict that Ventas, Inc. will post 3.4 earnings per share for the current fiscal year.

Ventas Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st were given a $0.48 dividend. The ex-dividend date was Wednesday, December 31st. This represents a $1.92 annualized dividend and a dividend yield of 2.5%. Ventas’s dividend payout ratio is currently 369.23%.

Analyst Upgrades and Downgrades

Several research analysts have commented on VTR shares. Wells Fargo & Company boosted their price target on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $93.00 price objective on shares of Ventas in a research note on Monday, January 5th. Jefferies Financial Group reissued a “buy” rating and issued a $93.00 price objective on shares of Ventas in a report on Monday, December 15th. Finally, Scotiabank raised their price objective on shares of Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 13th. Fourteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $81.63.

Insider Transactions at Ventas

In related news, CFO Robert F. Probst sold 33,591 shares of Ventas stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $76.77, for a total transaction of $2,578,781.07. Following the completion of the transaction, the chief financial officer directly owned 168,364 shares in the company, valued at $12,925,304.28. The trade was a 16.63% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Peter J. Bulgarelli sold 3,924 shares of the stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $75.00, for a total value of $294,300.00. Following the sale, the chief executive officer owned 112,564 shares in the company, valued at approximately $8,442,300. This trade represents a 3.37% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 494,005 shares of company stock valued at $37,132,767 in the last ninety days. Corporate insiders own 0.80% of the company’s stock.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.